Financhill
Back

Genmab AS 10K Form

Sell
29

GMAB
Genmab AS

Last Price:
22.76
Seasonality Move:
4.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GMAB News And Ratings

See the #1 stock for the next 7 days that we like better than GMAB

GMAB Financial Statistics

Sales & Book Value

Annual Sales: $2.39B
Cash Flow: $212.55M
Price / Cash Flow: 15.88
Annual Sales: $7.00
Price / Book: 3.25

Profitability

EPS (TTM): 1.21870
Net Income (TTM): $799.51M
Gross Margin: $2.36B
Return on Equity: 17.81%
Return on Assets: 15.53%

Genmab AS Earnings Forecast

Key Genmab AS Financial Ratios

  • The Gross Profit Margin over the past 17 years for GMAB is 98.63%.
  • The Selling, General & Administrative Expenses for GMAB have been equal to 20.01% of Gross Profit Margin.
  • The Research & Development expenses have been 46.32% of Revenue.
  • The Interest Expense is 0.62% of Operating Income.
  • The Net Earning history of GMAB is 26.42% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 15 years.

Genmab AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GMAB
Website: genmab.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.03
Quick Ratio: 5.02

Price-to-Earnings

Trailing P/E Ratio: 23.73
Forward P/E Ratio: 14.12

GMAB Technical Analysis vs Fundamental Analysis

Sell
29
Genmab AS (GMAB) is a Sell

Is Genmab AS a Buy or a Sell?

  • Genmab AS stock is rated a Sell
    The current Genmab AS [GMAB] share price is $22.75. The Score for GMAB is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.